862594-16-9

Basic information

• Product Name: 2-tert-butoxy-5-fluoroanilinedn
• Synonyms: 2-tert-butoxy-5-fluoroanilinedn;Benzenamine, 2-(1,1-dimethylethoxy)-5-fluoro-;EOS-60862
• CAS NO: 862594-16-9
• Molecular Formula: C₁₀H₁₄FNO
• Molecular Weight: 199.2220632
• Mol File: 862594-16-9.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-tert-butoxy-5-fluoroanilinedn(CAS DataBase Reference)
• NIST Chemistry Reference: 2-tert-butoxy-5-fluoroanilinedn(862594-16-9)
• EPA Substance Registry System: 2-tert-butoxy-5-fluoroanilinedn(862594-16-9)

Safety Data

• Hazardous Substances Data: 862594-16-9(Hazardous Substances Data)

Upstream product

• 364-74-9 1,4-difluoro-2-nitrobenzene 
• 142596-59-6 1-tert-butoxy-4-fluoro-2-nitrobenzene 

Downstream Products

• 663925-83-5 2-(benzyl-{2-[4-(4-phenyl-butoxy)-phenyl]-ethyl}-amino)-1-(4-tert-butoxy-2-isopropoxy-benzothiazol-7-yl)-ethanone 
• 663925-84-6 7-[(benzyl-{2-[4-(4-phenyl-butoxy)-phenyl]-ethyl}-amino)-acetyl]-4-hydroxy-3H-benzothiazol-2-one 
• 1247026-77-2 7-[(R)-2-((1S,2S)-2-benzyloxy-cyclopentylamino)-1-hydroxy-ethyl]-4-hydroxy-3H-benzothiazol-2-one 
• 663924-29-6 4-hydroxy-7-{(R)-1-hydroxy-2-[2-(4-propyl-phenyl)-ethylamino]-ethyl}-3H-benzothiazol-2-one hydrochloride 
• 862594-14-7 4-hydroxy-7-(1-hydroxy-2-{2-[4-(4-phenyl-butoxy)-phenyl]-ethylamino}-ethyl)-3H-benzo-thiazol-2-one 
• 663926-37-2 (R)-2-((1S,2S)-2-benzyloxy-cyclopentylamino)-1-(4-tert-butoxy-2-isopropoxy-benzothiazol-7-yl)-ethanol 
• 663925-82-4 O-isopropyl 2-tert-butoxy-5-fluorophenylthiocarbamate 

Relevant articles and documents

QUINOLONE COMPOUND AND PHARMACEUTICAL COMPOSITION

The present invention provides a quinolone compound represented by General Formula (1) or a salt thereof, wherein R1 represents a hydrogen atom, etc.; R2 represents a hydrogen atom, etc.; R3 represents a phenyl group optio

COMBINATION OF BENZOTHIAZOL-2-ONE BETA2 ADRENOCEPTOR AGONISTS AND CORTICOSTEROIDS FOR THE TREATMENT OF RESPIRATORY DISEASES

A medicament comprising, separately or together, (A) a compound of Formula (I) in free or salt or solvate form, wherein X has the meaning as indicated in the specification; and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.